1-2 of 2
Laura Stenson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Asciminib, a First-in-Class STAMP Inhibitor, Provides Durable Molecular Response in Patients (pts) with Chronic Myeloid Leukemia (CML) Harboring the T315I Mutation: Primary Efficacy and Safety Results from a Phase 1 Trial

Jorge E. Cortes, MD, Timothy P. Hughes, MDMBBS,FRACP,FRCPA, Michael J. Mauro, MD, Andreas Hochhaus, MD, Delphine Rea, MDPhD, Yeow Tee Goh, MBBS, Jeroen Janssen, Juan Luis Steegmann, Michael C. Heinrich, MD, Moshe Talpaz, MD, Gabriel Etienne, MD PhD, Massimo Breccia, MD, Michael W. Deininger, MD PhD, Philipp D le Coutre, MD, Fabian Lang, MD, Paola Aimone, MD, Fotis Polydoros, Silvia Cacciatore, Laura Stenson, Dong-Wook Kim, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 47–50.
https://doi.org/10.1182/blood-2020-139677
Published: 2020
Journal Articles

Canonical Notch signaling is dispensable for adult steady-state and stress myelo-erythropoiesis

Sara Duarte, Petter S. Woll, Natalija Buza-Vidas, Desmond Wai Loon Chin, Hanane Boukarabila, Tiago C. Luís, Laura Stenson, Tiphaine Bouriez-Jones, Helen Ferry, Adam J. Mead, Deborah Atkinson, Shaobo Jin, Sally-Ann Clark, Bishan Wu, Emmanouela Repapi, Nicki Gray, Stephen Taylor, Anders P. Mutvei, Yat Long Tsoi, Claus Nerlov, Urban Lendahl, Sten Eirik W. Jacobsen
Journal: Blood
Blood (2018) 131 (15): 1712–1719.
https://doi.org/10.1182/blood-2017-06-788505
Published: 2018
Includes: Supplemental data